Evidence map›Paper›PMID 41048266›Full record

ArticleFrontiers in public health2025

Building a diagnostic prediction model for severe

Chuxiong Gong, Helang Yue, Qinhong Li, Yanfei Yang, Hongyan Li, Tingting Hao, Hongrui Wu, Yanwei Xu, Qiyin Huang, Xingzhu Liu and 1 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Machine learning-based prediction models for severeFrontiers in public health · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Early prediction of plastic bronchitis in pediatric patients withFrontiers in cellular and infection microbiology · 2026
    Article
  6. Nomogram to predict severeFrontiers in pediatrics · 2026
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chuxiong Gong *Department of Cardiology, Kunming Children's Hospital, Kunming, Yunnan, China.
Helang Yue *Kunming Medical University, Kunming, Yunnan, China.
Qinhong Li *Department of Cardiology, Kunming Children's Hospital, Kunming, Yunnan, China.
Yanfei YangDepartment of Special Needs Ward, Kunming Children's Hospital, Kunming, Yunnan, China.
Hongyan LiKunming Medical University, Kunming, Yunnan, China.
Tingting HaoDepartment of Special Needs Ward, Kunming Children's Hospital, Kunming, Yunnan, China.
Hongrui WuMedical College of Dali University, Dali, Yunnan, China.
Yanwei XuMedical College of Dali University, Dali, Yunnan, China.
Qiyin HuangMedical College of Dali University, Dali, Yunnan, China.
Xingzhu LiuDepartment of Special Needs Ward, Kunming Children's Hospital, Kunming, Yunnan, China.
Yuqin WuDepartment of Special Needs Ward, Kunming Children's Hospital, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods: We collected medical records from 372 MPP cases. We compared case characteristics between groups with and without SMPP and used a random forest to screen key factors. We then constructed a multivariate logistic prediction model. We evaluated the model with ROC curves, calibration curves, and DCA. Five-fold cross-validation tested prediction stability. Results: We identified ESR, PCT, IL-6, and lung auscultation as key factors to construct the prediction model. The model's ROC was 0.964 (95% CI: 0.945-0.983). Calibration curves and DCA confirmed model accuracy. Five-fold cross-validation validated internal stability. Conclusion: Our study developed a prediction model with good efficacy for early SMPP risk assessment. Our research provides a basis for clinical early prediction and prevention of SMPP, reducing its risk and offering a foundation for individualized treatment and improved long-term outcomes in affected children.

Indexed as

Machine LearningPneumonia, MycoplasmaChildChild, PreschoolFemaleHumansInfantMaleMycoplasma pneumoniaeROC CurveSeverity of Illness IndexLASSOMycoplasma pneumoniae pneumoniapredictive modelrandom forestsevere Mycoplasma pneumoniae pneumonia

Identifiers

PMID41048266
PMCPMC12488690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.